Failure of asparagine (ASN) depletion, not inadequate asparaginase (ASNase) activity, predicts relapse in standard risk (SR) childhood acute lymphoblastic leukemia (ALL): A Children's Oncology Group (COG) report

被引：3
|
作者：
Avramis, Vassilios I. [1 ]
Holcenberg, John S. [1 ]
Ettinger, Alice G. [1 ]
Stork, Linda C. [1 ]
La, Mei [1 ]
Gaynon, Paul S. [1 ]
机构：
[1] Childrens Oncol Grp, Arcadia, CA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.588.588
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
588
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [31] Outcome after first relapse in children with acute lymphoblastic leukemia: a report based on the Dutch Childhood Oncology Group (DCOG) relapse all 98 protocol
    Yamanaka, Junko
    Ogawa, Chitose
    Arakawa, Ayumu
    Deguchi, Takao
    Hori, Toshinori
    Kiyokawa, Nobutaka
    Ueki, Hideaki
    Nishi, Masanori
    Mochizuki, Shinji
    Nishikawa, Takuro
    Kumamoto, Tadashi
    Nishiuchi, Ritsuo
    Kikuta, Atsushi
    Yamamoto, Shohei
    Koh, Katsuyoshi
    Hasegawa, Daisuke
    Ogawa, Atsushi
    Watanabe, Kenichiro
    Sato, Atsushi
    Saito, Akiko M.
    Watanabe, Tomoyuki
    Manabe, Atsushi
    Horibe, Keizo
    Goto, Hiroaki
    Toyoda, Hidemi
    PEDIATRIC BLOOD & CANCER, 2024, 71 (12)
  • [32] Executive Functioning in Children and Adolescents Treated for High-Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report from The Children's Oncology Group (COG)
    Hardy, K.
    Gioia, A.
    Kairalla, J.
    Winick, N.
    Noll, R.
    Patel, S.
    Sands, S.
    Embry, L.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S35 - S36
  • [33] Prospective assessment of chemotherapy-induced peripheral neuropathy (CIPN) in children with standard-risk acute lymphoblastic leukemia (SR ALL): Results of Children's Oncology Group (COG) AALL0932.
    Kadan-Lottick, Nina S.
    Lu, Xiaomin
    Hockenberry, Marilyn
    Whitley, Moira K.
    Hunger, Stephen
    Devidas, Meenakshi
    Winick, Naomi Joan
    Schore, Reuven J.
    Angiolillo, Anne L.
    Ness, Kirsten K.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] INTENSIVE VINCRISTINE IS NOT FEASIBLE IN INTERMEDIATE-RISK RELAPSE OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A REPORT FROM CHILDREN'S ONCOLOGY GROUP STUDY AALL0433
    Lew, Glen
    Yanofsky, Rochelle
    Winick, Naomi
    Rheingold, Susan
    Jorstad, Dean
    Lu, Xiaomin
    Devidas, Meenakshi
    Whitlock, James
    Hunger, Stephen
    Carroll, William
    PEDIATRIC BLOOD & CANCER, 2011, 56 (06) : 919 - 919
  • [35] Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia A Children's Oncology Group Study
    Bhatia, Smita
    Landier, Wendy
    Hageman, Lindsey
    Chen, Yanjun
    Kim, Heeyoung
    Sun, Can-Lan
    Kornegay, Nancy
    Evans, William E.
    Angiolillo, Anne L.
    Bostrom, Bruce
    Casillas, Jacqueline
    Lew, Glen
    Maloney, Kelly W.
    Mascarenhas, Leo
    Ritchey, A. Kim
    Termuhlen, Amanda M.
    Carroll, William L.
    Wong, F. Lennie
    Relling, Mary V.
    JAMA ONCOLOGY, 2015, 1 (03) : 287 - 295
  • [36] Effect of dexamethasone (DEX) dose modification on osteonecrosis (ON) risk associated with intensified therapies for standard risk acute lymphoblastic leukemia (SR-ALL): A report from the Children's Oncology Group (COG) study AALL0331.
    Mattano, Leonard A.
    Devidas, Meenakshi
    Friedmann, Alison M.
    Raetz, Elizabeth A.
    Hunger, Stephen
    Winick, Naomi Joan
    Carroll, William L.
    Maloney, Kelly W.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Body mass index during maintenance therapy and relapse risk in children with acute lymphoblastic leukemia: A Children's Oncology Group report
    Wadhwa, Aman
    Chen, Yanjun
    Hageman, Lindsey
    Hoppmann, Anna L.
    Angiolillo, Anne
    Dickens, David S.
    Lew, Glen
    Neglia, Joseph P.
    Ravindranath, Yaddanapudi
    Ritchey, A. Kim
    Termuhlen, Amanda
    Wong, F. Lennie
    Landier, Wendy
    Bhatia, Smita
    CANCER, 2023, 129 (01) : 151 - 160
  • [38] Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse:: A children's oncology group study (CCG-1941)
    Jarrar, Mohammad
    Gaynon, Paul S.
    Periclou, Antonia P.
    Fu, Cecilia
    Harris, Richard E.
    Stram, Daniel
    Altman, Arnold
    Ostrom, Bruce
    Breneman, John
    Steele, David
    Trigg, Michael
    Zipf, Theodore
    Avramis, Vassilios I.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (02) : 141 - 146
  • [39] Pharmacodynamic (PD) analyses of asparagine (Asn) deamination and Asn input (Imax) in serum of pediatric patients with standard risk acute lymphoblastic leukemia (SR ALL) receiving native or pegylated E. coli asparaginases (ASNase) (CCG-1962).
    Avramis, VI
    Panosyan, EH
    Fu, CH
    Stork, LC
    Gaynon, PS
    BLOOD, 2004, 104 (11) : 573A - 573A
  • [40] Increased Incidence of Osteonecrosis (ON) with a Dexamethasone (DEX) Induction for High Risk Acute Lymphoblastic Leukemia (HR-ALL): A Report from the Children's Oncology Group (COG).
    Mattano, Leonard A., Jr.
    Nachman, James B.
    Devidas, Meenakshi
    Winick, Naomi
    Raetz, Elizabeth
    Carroll, William L.
    Whitlock, James A.
    Hunger, Stephen P.
    Larsen, Eric C.
    BLOOD, 2008, 112 (11) : 333 - 334
12345